Connect Biopharma is trading 29.35% down now at $1.22, after closing at $1.73 on September 14, 2026; no clear company-specific announcement has been identified to explain the September 15 decline.
- Management is scheduled to participate in an H.C. Wainwright fireside chat at 11:30 a.m. EDT.
- Broader markets are only modestly weaker.
- The company previously said September trial results were expected, but no new results were reported in available coverage.